We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
An FDA advisory board review of the agency’s adverse event reporting system (AERS) has found that the system is failing to provide the FDA with the information it needs to detect emerging safety issues.